6 0 5 l e t t e r s rs4635969 are maintained when corrected for each other by logistic regression (OR = 1.26, 95% CI 1.17-1.36, P = 8.71 × 10 −9 , and OR = 1.46, 95% CI 1.34-1.60, P = 2.22 × 10 −16 , respectively). Furthermore, correlation between rs2736100 and rs4635969 was poor (D′ = 0.019, r 2 = 0 in HapMap CEU samples, D′ = 0.41, r 2 = 0.04 in our GWAS control data), and comparison of haplotype frequencies provided evidence of two haplotypes differing in frequency between cases and controls (Supplementary Table 2 ). Taken together, these data strongly suggest that rs2736100 and rs4635969 are independently associated with TGCT. rs2736100 and rs4635969 lie within a 103-kb region on 5p15 (at 1,306-1,409 kb) that comprises a 41-kb region of recombination overlying TERT (encoding human telomerase reverse transcriptase) followed by a 62-kb linkage disequilibrium (LD) block overlying the 3′ end of TERT and CLPTM1L (encoding cisplatin-resistance-related protein CRR9p). rs2736100 lies in intron 2 of TERT in the upstream recombination region, whereas rs4635969 lies 5′ of CLPTM1L in the LD block (Fig. 1a) .
l e t t e r s
We conducted a genome-wide association study for testicular germ cell tumor, genotyping 298,782 SNPs in 979 affected individuals and 4,947 controls from the UK and replicating associations in a further 664 cases and 3,456 controls. We identified three new susceptibility loci, two of which include genes that are involved in telomere regulation. We identified two independent signals within the TERT-CLPTM1L locus on chromosome 5, which has previously been associated with multiple other cancers (rs4635969, OR = 1.54, P = 1.14 × 10 −23 ; rs2736100, OR = 1.33, P = 7.55 × 10 −15 ). We also identified a locus on chromosome 12 (rs2900333, OR = 1.27, P = 6.16 × 10 −10 ) that contains ATF7IP, a regulator of TERT expression. Finally, we identified a locus on chromosome 9 (rs755383, OR = 1.37, P = 1.12 × 10 −23 ), containing the sex determination gene DMRT1, which has been linked to teratoma susceptibility in mice.
Testicular germ cell tumor (TGCT) is the most common malignancy in men aged 15-45 (ref. 1) . There are two major subgroups of TGCT: seminomas (comprising 50% of cases), which resemble the primary germ cells from which they are derived, and non-seminomas (comprising 40% of cases), which display varying degrees of differentiation, from embryonal carcinoma through to teratoma. About 10% of tumors contain mixed histology 2 . Recognized risk factors for TGCT include previous germ cell tumor, a family history of TGCT, subfertility, testicular microlithiasis and abnormalities of testicular development, such as undescended testis [2] [3] [4] .
The familial relative risk of TGCT is high; studies have estimated the risk to brothers and sons of TGCT cases to be increased 8-to 10-fold and 4-to 6-fold, respectively 3 . Genome-wide genetic linkage analysis has not provided evidence for the location of a TGCT predisposition gene; many candidate association studies have been undertaken but to date have only unequivocally identified rare deletions on the Y chromosome that confer a modest increase in risk of TGCT 5, 6 .
Two recent genome-wide association studies (GWAS) of TGCT identified associations with loci on chromosome 12q21 encompassing KITLG (OR = 2.55, P = 10 −31 ), on chromosome 5q31 encompassing SPRY4 (OR = 1.37, P = 3 × 10 −13 ) and on chromosome 6p21 encompassing BAK1 (OR = 1.50, P = 10 −13 ) 7, 8 . Here we undertook a further GWAS of TGCT, genotyping 1,056 cases on the Illumina HumanCNV370-Duo bead array, of which 730 were included in our first study 7 . The genotype frequencies were compared to those from 5,069 controls genotyped on the Illumina 1.2 M array by the Wellcome Trust Case Control Consortium 2. Data on 314,861 SNPs common to both arrays were included in this analysis. Following standard qualitycontrol filters and exclusions, we analyzed 298,782 SNPs in 979 TGCT cases and 4,947 controls (see Online Methods). Genotype frequencies in cases and controls were compared using a 1-degree-of-freedom (1-d.f.) Cochran-Armitage trend test ( Table 1 ; for quantile-quantile plot, see Supplementary Fig. 1) . Comparison of the observed and expected distributions showed evidence of only modest inflation in the test statistic, thereby rendering substantial hidden population stratification or differential genotype calling unlikely (inflation factor (λ) = 1.078, equivalent to λ 1,000 = 1.045 for a study of 1,000 cases and 1,000 controls).
We identified 33 SNPs at six loci showing association at P < 10 −6 (Supplementary Table 1 ). Twenty SNPs were within the previously identified three loci at 5q31, 6p21 and 12q21, and their odds ratios were consistent with those previously published 7 . Thirteen further SNPs at three new loci on chromosomes 5p15 (five SNPs), 9p24 (six SNPs) and 12p13 (two SNPs) showed association at P < 10 −6 .
Following multiple logistic regression analyses to test for independence of effects, we selected four SNPs for follow-up: rs2736100 and rs4635969 at 5p15, rs755383 at 9p24 and rs2900333 at 12p13. These SNPs were genotyped in an additional 664 TGCT cases and 3,456 controls using Taqman assays (see Online Methods). Each of the four SNPs showed evidence of replication ( Table 1) .
We identified two SNPs on 5p15 (rs2736100 and rs4635969) associated with TGCT susceptibility (Fig. 1) . The effects of rs2736100 and l e t t e r s rs4635969 are maintained when corrected for each other by logistic regression (OR = 1.26, 95% CI 1.17-1.36, P = 8.71 × 10 −9 , and OR = 1.46, 95% CI 1.34-1.60, P = 2.22 × 10 −16 , respectively). Furthermore, correlation between rs2736100 and rs4635969 was poor (D′ = 0.019, r 2 = 0 in HapMap CEU samples, D′ = 0.41, r 2 = 0.04 in our GWAS control data), and comparison of haplotype frequencies provided evidence of two haplotypes differing in frequency between cases and controls (Supplementary Table 2 ). Taken together, these data strongly suggest that rs2736100 and rs4635969 are independently associated with TGCT. rs2736100 and rs4635969 lie within a 103-kb region on 5p15 (at 1,306-1,409 kb) that comprises a 41-kb region of recombination overlying TERT (encoding human telomerase reverse transcriptase) followed by a 62-kb linkage disequilibrium (LD) block overlying the 3′ end of TERT and CLPTM1L (encoding cisplatin-resistance-related protein CRR9p). rs2736100 lies in intron 2 of TERT in the upstream recombination region, whereas rs4635969 lies 5′ of CLPTM1L in the LD block (Fig. 1a) .
The TERT-CLPTM1L locus on 5p15 is the third region shown to be associated with multiple cancers, the other two being at 8q24 and 9p21 (refs. 9-15) . Associations of SNPs in the upstream region of recombination on 5p15 have been reported in lung cancer (rs2736100 and rs2736098) [10] [11] [12] , specifically adenocarcinoma of the lung (rs2736100) 11 , glioma (rs2736100 and rs2853676) 14 , and basal cell carcinoma and carcinomas of the urinary bladder and prostate (rs2736098) 12 . Associations of SNPs in the downstream LD block have been reported in basal cell carcinoma, cutaneous melanoma and carcinomas of the urinary bladder, cervix, prostate (rs401681) 12, 13 , lung (rs401681, rs402710 and rs4635969) [9] [10] [11] [12] and pancreas (rs401681 and rs4635969) 15 .
Associations of rs401681 (P = 1.17 × 10 −6 ) and rs402710 (P = 1.38 × 10 −4 ) with TGCT were evident in our GWAS data. However, these SNPs are both correlated with rs4635969, and the associations at rs401681 and rs402710 disappeared with correction for rs4635969, suggesting a single signal driving the association in our data; this signal is best represented by rs4635969 (Supplementary Tables 3, 4 l e t t e r s and 5). We also identified a strong association with rs2853676 (P = 8.70 × 10 −7 ); this association remained significant when corrected for either rs2736100 or rs4635969 but disappeared with simultaneous correction for both rs2736100 and rs4635969. Because neither rs2736100 nor rs4635969 alone can fully account for the association observed between TGCT and sequence variants in this region, it is plausible that a unique causal variant in LD with and capturing the effects of both rs2736100[T] and rs4635969[T] may exist. However, we identified no association more significant than that of rs4635969 through imputation in our data of 3.96 million SNPs, so it is equally plausible that two separate signals exist (see Online Methods and Supplementary Table 6 ). To investigate these alternatives, further analyses of the 5p15 locus will be required in the various cancers in which it has been implicated. There are two genes within the 5p15 locus through which the association might plausibly be mediated: CLPTM1L and TERT. CLPTM1L is expressed in a range of normal and malignant tissues and has been shown to sensitize ovarian cancer cells to cisplatin-induced apoptosis 16 . Malignant testicular germ cells are extremely sensitive to cisplatin, a fact that has revolutionized the treatment of TGCT and that represents one of the great successes of cancer chemotherapy 17 . Nevertheless, it would seem most likely that the 5p15 signals are mediated through TERT, which encodes the catalytic subunit of the telomerase ribonucleoprotein complex. At each division of actively dividing cells, there is loss of terminal sequences. Telomerase counterbalances this by extending the TTAGGG telomeric nucleotide repeats. Telomere shortening is associated with increased genome instability and neoplasia 18, 19 . Furthermore, TERT is reactivated in cancer cells, which serves to extend the replicative lifespan of tumor cells beyond that of their normal counterparts 20 . Consistent with this, amplification of the 5p15 region has been reported in several cancer types 21, 22 .
Although TERT is expressed throughout the developing embryo, it is typically absent in normal benign adult somatic cells. Emergence of a link between TERT and TGCT is therefore particularly notable, as testicular germ cells are unique in being the only normal adult tissue in which telomerase is highly expressed 23 . Moreover, it has been observed that undifferentiated TGCTs (seminomas) exhibit the pattern of high TERT expression, high telomerase activity and long telomeres seen in normal testicular germ cells, whereas welldifferentiated TGCTs such as teratomas show minimal TERT expression and no telomerase activity 23, 24 . There is some reflection of this dichotomy in our data, as the association of rs2736100 was stronger with seminomas (OR = 1.48, 95% CI 1.32-1.66) than non-seminomas (OR = 1.26, 95% CI 1.12-1.42, P = 0.04; see Online Methods and Supplementary Tables 7 and 8) .
Telomerase regulation is also implicated as underlying the association of the locus on chromosome 12p13. Here rs2900333 lies in a 181-kb LD block (Fig. 1b) containing a single gene, ATF7IP (encoding the activating transcription factor 7 interacting protein; also known as MCAF1 and MBD1-containing chromatin-associated factor 1). ATF7IP encodes a transcription factor that enables expression of TERT and its associated RNA component, which is encoded by TERC. Knockdown of ATF7IP in HeLa cells causes marked reductions in TERT and TERC expression and in telomerase activity 25 . Furthermore, ATF7IP is frequently overexpressed in cancers 25 .
The third locus is located at 9p24 in an LD block of 76 kb (Fig. 1c ) in which there is only one annotated protein-coding gene, DMRT1 (encoding doublesex and mab-3 related transcription factor 1). There is considerable evidence linking this gene to testicular determination, differentiation and tumorigenesis, rendering it a highly plausible candidate through which the association with TGCT may be mediated.
The strongest evidence comes from mouse studies which demonstrated that Dmrt1 deficiency is associated with testicular cancer: 90% of Dmrt1 −/− 129Sv mice developed teratomas compared to <1% of Dmrt1 +/+ mice 26 . DMRT1 is a transcription factor with a highly conserved DNA-binding motif. Phylogenetic studies suggest that, despite widespread differences in sex-determining mechanisms, DMRT1 represents an ancient conserved component common to many vertebrate sex-determining pathways 27 . The distinct cell type-dependent, stage-dependent and sexually dimorphic expression profile of DMRT1 during embryogenesis is consistent with high DMRT1 expression being required for testicular differentiation, whereas lower expression results in ovarian differentiation 27 . DMRT1 has further been implicated in human sex differentiation, as abnormal male gonadal development is associated with deletions of the 9p24.3 region 28 that contains DMRT1. Furthermore, germ cell tumors arise in a substantial proportion of these deletion cases 29 .
To date, eight TGCT predisposition SNPs at six loci have been identified. In this GWAS, we have identified rs2736100 and rs4635969 at the TERT-CLPTM1L locus on 5p15, rs2900333 at the ATF7IP locus on 12p13 and rs755383 at the DMRT1 locus on 9p24, and in our previous GWAS 7 , we identified rs995030 and rs1508595 at the KITLG locus on 12q21, rs4624820 at the SPRY4 locus on 5q31 and rs210138 at the BAK1 locus on 6p21. The four newly identified susceptibility alleles together account for 4% of the risk to the brothers and 6% of the risk to the sons of individuals with TGCT, bringing the cumulative total of the eight susceptibility alleles identified to date to 11% and 16%, respectively. No SNP showed evidence of departure from a logadditive (multiplicative) model: that is, the OR for rare homozygotes did not differ significantly from the square of the OR for heterozygotes (Table 1) . Similarly, there was no evidence of statistical interaction between any pair of these eight SNPs; for every combination of SNPs, the combined risk was consistent with the product of the individual risks. Under this multiplicative model, those in the top 10% of genetic risk have a relative risk ~3-fold greater than the general population, whereas those classified as the bottom 10% of genetic risk are estimated to have a relative risk of about one-sixth of the population risk.
Genome-wide association studies of TGCT have thus far led to the emergence of three key, distinct pathways, each of which is biologically plausible in its involvement in TGCT predisposition. KITLG, SPRY4 and BAK1 are all involved in the KIT pathway. KITLG encodes the KIT ligand (also known as the stem cell factor), which activates the receptor tyrosine kinase KIT; somatic KIT mutations and amplifications are well recognized in germ cell tumors. SPRY4 acts in the mitogen-activated protein kinase pathway, which is activated by the KITLG-KIT system, whereas BAK1 encodes a pro-apoptotic protein, expression of which is repressed by the KITLG-KIT system in testicular germ cells. TERT and ATF7IP relate to a second pathway of telomerase regulation: TERT encodes telomerase and ATF7IP regulates expression of TERT and its partner TERC. DMRT1 relates to a third pathway of sex determination. Although the known functions of these genes render them highly plausible candidates through which the associations to TGCT may be mediated, finer association mapping, expression analyses in testicular germ cells and functional analyses will be required to uncover the true causative variants and mechanisms of cancer predisposition.
The power to detect these new loci on chromosome 5p15 (rs2736100 and rs46359699), 9p24 and 12p13 was 49%, 95%, 69% and 17%, respectively. Thus, although it is unlikely that many common alleles of larger effects have been missed in this analysis, multiple further loci of similar and weaker effects may exist, which could explain more of the residual familial risk of testicular germ cell cancer. l e t t e r s MethOdS Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
